Barrett’s esophagus with high grade dysplasia: Surgical results and long-term outcome— An update

[1]  A. Sonnenberg,et al.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.

[2]  Prateek Sharma,et al.  Long-term follow-up of Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.

[3]  Gary Longton,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.

[4]  C. A. Pellegrini,et al.  High-Grade dysplasia in Barrett’s esophagus: Surveillance or operation? , 2000, Journal of Gastrointestinal Surgery.

[5]  W. Souba,et al.  Management of Barrett’s esophagus , 2000, Journal of Gastrointestinal Surgery.

[6]  T. Demeester,et al.  Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. , 2000, Annals of surgery.

[7]  A. Weston,et al.  Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma , 1999, American Journal of Gastroenterology.

[8]  G. Falk,et al.  The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the cleveland clinic barrett's esophagus registry , 1999, American Journal of Gastroenterology.

[9]  A. Cameron,et al.  Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. , 1997, The American journal of gastroenterology.

[10]  R. Heitmiller,et al.  Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. , 1996, Annals of surgery.

[11]  R. Lebovitz,et al.  p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. , 1993, Gastroenterology.

[12]  T. Rice,et al.  Surgical management of high-grade dysplasia in Barrett's esophagus. , 1993, The American journal of gastroenterology.

[13]  P. Pairolero,et al.  Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? , 1992, The Annals of thoracic surgery.

[14]  P. Blount,et al.  Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. , 1992, Gastroenterology.

[15]  G. Tytgat,et al.  The neoplastic potential of columnar-lined (Barrett's) esophagus , 1992, World Journal of Surgery.

[16]  N. Walker,et al.  Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. , 1991, Gut.

[17]  J. G. van den Tweel,et al.  Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.

[18]  J. Mayberry,et al.  Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.

[19]  B. Reid,et al.  Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. , 1987, Gastroenterology.

[20]  R. R. Smith,et al.  The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. , 1987, American journal of clinical pathology.

[21]  P. Blount,et al.  Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.